Executives @LillyPad may be raging about losing market cap due to Twitter prank. But how about losing your life because you, like 1.3 million other diabetic Americans are forced to ration insulin? Our research in @AnnalsofIM https://t.co/HZQMihCJSF
UPDATE—Just learned that Eli Lilly executives are raging and furious at losing $20 billion in market cap from this stunt with @TwitterBlue. It’s too bad they don’t see their own damn insulin price gouging as the actual problem. Karma @LillyPad, karma.
Our new study just up in JAMA IM: we track Americans' out-of-pocket health spending longitudinally over a four-year period, showing that risks mount year after year. Whereas 11.8% of adults experience healthcare financial strain after 1 year, risk rises to 26.7% over four years
@ashishkjha@TheLancet@bhrenton If anyone is interested in understanding why Ashish’s graph is incorrect, we have explained this on Ashish’s Substack where he details his (flawed) methodology. In brief, Ashish and his research associate did not appropriately deal with data discontinuities.
Our article in Health Affairs Forefront on the “real waste, fraud, and abuse” in healthcare — Medicare and Medicaid privatization — is now up.
MA Overpayments & excess Medicaid managed care overhead could cost as much as $1.9 trillion in coming decade.
https://t.co/6hWEI2OyTt
Recent Experience Shows National Medicaid Work Requirements Would Create Enormous Administrative Inefficiencies | out today in Health Affairs https://t.co/L8Y7p6BJBZ
Our profit-oriented health insurance system traps parents of kids with cystic fibrosis in dead end jobs: study in @JAMAPediatrics https://t.co/f8i4MwfD0v
⚡ OUT NOW ⚡
The 2024 Report of the Lancet Countdown on Health and Climate Change: Facing record-breaking threats from delayed action.
Read the latest assessment of the links between health and climate change: https://t.co/FgQsL7nIV3 #LancetClimate24